Emerging evidence (particularly for hepatocellular carcinoma) suggests that TERT could interact with BAP1 via the WNT/β-catenin signaling pathway, which is often activated in tumors with TERT overexpression. This evidence concerns the gene BAP1 and hepatocellular carcinoma.